A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults
- 17 April 2009
- Vol. 27 (28) , 3744-3753
- https://doi.org/10.1016/j.vaccine.2009.03.082
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- A Live Attenuated H9N2 Influenza Vaccine Is Well Tolerated and Immunogenic in Healthy AdultsThe Journal of Infectious Diseases, 2009
- Role of Interferon in the Replication of Human Parainfluenza Virus Type 1 Wild Type and Mutant Viruses in Human Ciliated Airway EpitheliumJournal of Virology, 2008
- Amino Acid 226 in the Hemagglutinin of H4N6 Influenza Virus Determines Binding Affinity for α2,6-Linked Sialic Acid and Infectivity Levels in Primary Swine and Human Respiratory Epithelial CellsJournal of Virology, 2008
- Vaccines: Correlates of Vaccine‐Induced ImmunityClinical Infectious Diseases, 2008
- A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferretsVirology, 2008
- Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibilityProceedings of the National Academy of Sciences, 2008
- Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccineVaccine, 2008
- Development and Evaluation of an Influenza Virus Subtype H7N2 Vaccine Candidate for Pandemic PreparednessClinical and Vaccine Immunology, 2007
- Infection Due to 3 Avian Influenza Subtypes in United States VeterinariansClinical Infectious Diseases, 2007
- Comparison of the Influenza Virus-Specific Effector and Memory B-Cell Responses to Immunization of Children and Adults with Live Attenuated or Inactivated Influenza Virus VaccinesJournal of Virology, 2007